Terumo Corp
TSE:4543
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 129.2177
3 160
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Terumo Corp
Net Income (Common)
Terumo Corp
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Terumo Corp
TSE:4543
|
Net Income (Common)
ÂĄ119.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
||
Olympus Corp
TSE:7733
|
Net Income (Common)
ÂĄ16.6B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
||
Sysmex Corp
TSE:6869
|
Net Income (Common)
ÂĄ53.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
||
Nihon Kohden Corp
TSE:6849
|
Net Income (Common)
ÂĄ14B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
2%
|
||
JEOL Ltd
TSE:6951
|
Net Income (Common)
ÂĄ25.1B
|
CAGR 3-Years
66%
|
CAGR 5-Years
34%
|
CAGR 10-Years
21%
|
||
Fukuda Denshi Co Ltd
TSE:6960
|
Net Income (Common)
ÂĄ18.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
Terumo Corp
Glance View
Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, has carved a significant niche in the global healthcare landscape as a leader in medical technology. With a steadfast commitment to enhancing the quality of life, Terumo focuses on innovative solutions in areas such as blood management, cardiovascular interventions, and surgical devices. Through a history of groundbreaking research and development, Terumo has established a robust portfolio of products that not only meet immediate clinical needs but also pave the way for advancements in patient care. The company’s dedication to sustainability and social responsibility further solidifies its reputation as a trustworthy and forward-thinking organization committed to making a positive impact on society. For investors, Terumo presents an attractive opportunity characterized by steady growth, a diverse global presence, and a solid financial foundation. The company's strategic focus on expanding its international footprint, particularly in emerging markets, positions it to capitalize on the rising demand for healthcare innovations. With an increasingly aging population and a growing emphasis on preventative care and advanced treatments, Terumo's comprehensive array of products is well-placed to address these market dynamics. As it continues to invest in R&D and forge strategic partnerships, Terumo Corporation not only stands as a resilient player in the medical technology sector but also as a company poised for long-term growth and value creation for its shareholders.
See Also
What is Terumo Corp's Net Income (Common)?
Net Income (Common)
119.5B
JPY
Based on the financial report for Sep 30, 2024, Terumo Corp's Net Income (Common) amounts to 119.5B JPY.
What is Terumo Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%
Over the last year, the Net Income (Common) growth was 21%. The average annual Net Income (Common) growth rates for Terumo Corp have been 8% over the past three years , 6% over the past five years , and 13% over the past ten years .